Clinical Trial Update: Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ixazomib in combination with cyclophosphamide and dexamethasone for newly diagnosed AL amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• ixazomib (ixazomib)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: AL Amyloidosis | Phase 1, Phase 2 | Status: COMPLETED